Elisa Espinet receives a FERO grant to investigate the mechanisms of resistance to new therapies against pancreatic cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The researcher will study how the tumour environment influences the response to Pan-KRAS inhibitors, one of the most promising therapeutic strategies against pancreatic ductal adenocarcinoma.

Read more

La pista escondida en el ARN que podría ayudar a tratar y frenar el cáncer de próstata

by Universidad de Salamanca

La investigación del Centro de Investigación del Cáncer, liderada por Sandra Blanco, explora el potencial del epitranscriptoma para desarrollar nuevos fármacos capaces de mejorar la respuesta a lo...

Read more

Anna Bigas co-leads a new project on T-cell Acute Lymphoblastic Leukaemia, funded by the Deutsche José Carreras Leukämie Stiftung

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The project aims to determine how genetic alterations affecting the BAF complex, and the epigenetic changes they trigger, contribute to treatment resistance and disease progression.

Read more

A study by IRB Barcelona and the BSC rethinks the origin of our cells as a story of microbial alliances

by IRB Barcelona - Instituto de Investigación Biomédica

Published in Nature, the team led by Dr. Toni Gabaldón used the MareNostrum supercomputer to reconstruct the genetic origin of the last common ancestor of all eukaryotes—the cellular lineage to whi...

Read more

The University of Barcelona Science Park reaches a new investment record of €230 million in 2025

by Parc Científic de Barcelona

The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of €229.7 million raised by the companies in its ecosystem. Start-ups, spin-offs a...

Read more

Un estudio internacional evalúa la seguridad y beneficio de un nuevo tratamiento para prevenir complicaciones neurológicas en pacientes con cirrosis hepática

by INCLIVA

La investigación ha analizado la seguridad y el comportamiento en el organismo de una terapia experimental dirigida a reducir los niveles de amonio en sangre

Read more

Todd Yeates, inventor of ‘protein Lego’, will design nanomolecules with therapeutic potential as a Fundación Occident Visiting Researcher at CNIO

by CNIO - Centro Nacional de Investigaciones Oncológicas

Yeates is the inventor of protein nanoparticles that assemble themselves, much like ‘Lego’ bricks. They are used to visualise very small proteins that are targets for anti-cancer drugs.

Read more

Álvarez-Vallina aims to generate STAb-T cells against multiple myeloma directly in the body

by CNIO - Centro Nacional de Investigaciones Oncológicas

The HMarBCN -CNIO Cancer Immunotherapy Clinical Research Unit has just received funding from the Deutsche José Carreras Leukämie Stiftung for a project aimed at modifying T cells directly within the...

Read more

Shilpa Biocare invests in Gate2Brain, an IRB Barcelona spin-off, to advance an innovative therapeutic candidate for brain cancer

by IRB Barcelona - Instituto de Investigación Biomédica

Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.

Read more

Conocer las alteraciones del entorno inmunitario permite anticipar la transformación agresiva del linfoma folicular

by Cima Universidad de Navarra

Un estudio liderado por hematólogos del Cancer Center Clínica Universidad de Navarra ha analizado este tumor célula a célula y ha descubierto que, cuando evoluciona, las defensas presentan menor c...

Read more

Una molécula experimental logra ‘reprogramar’ las defensas del cerebro frente al alzhéimer

by CSIC - Centro Superior de Investigaciones Científicas

Un estudio del Instituto de Neurociencias (CSIC-UMH) muestra en modelos animales cómo este compuesto reduce el tamaño y la toxicidad de las sustancias que generan esta enfermedad

Read more

IGTP researchers identify a potential therapeutic strategy for malignant tumours associated with neurofibromatosis type 1

by Hospital Universitari Germans Trias i Pujol

The study, published in Nature Communications, develops a new cellular model that reproduces the progression of NF1-associated tumours and enables the identification of new therapeutic opportunities.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Researchers Discover How Acute Myeloid L...

by Institut de Recerca Sant Pau

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...

Photos Stream